183 related articles for article (PubMed ID: 27832954)
21. One-step continuous extrusion process for the manufacturing of solid dispersions.
Maniruzzaman M; Nair A; Scoutaris N; Bradley MS; Snowden MJ; Douroumis D
Int J Pharm; 2015 Dec; 496(1):42-51. PubMed ID: 26403386
[TBL] [Abstract][Full Text] [Related]
22. Solid-state, triboelectrostatic and dissolution characteristics of spray-dried piroxicam-glucosamine solid dispersions.
Adebisi AO; Kaialy W; Hussain T; Al-Hamidi H; Nokhodchi A; Conway BR; Asare-Addo K
Colloids Surf B Biointerfaces; 2016 Oct; 146():841-51. PubMed ID: 27451373
[TBL] [Abstract][Full Text] [Related]
23. Physicochemical properties of tadalafil solid dispersions - Impact of polymer on the apparent solubility and dissolution rate of tadalafil.
Wlodarski K; Sawicki W; Haber K; Knapik J; Wojnarowska Z; Paluch M; Lepek P; Hawelek L; Tajber L
Eur J Pharm Biopharm; 2015 Aug; 94():106-15. PubMed ID: 25998701
[TBL] [Abstract][Full Text] [Related]
24. Evolution of supersaturation of amorphous pharmaceuticals: nonlinear rate of supersaturation generation regulated by matrix diffusion.
Sun DD; Lee PI
Mol Pharm; 2015 Apr; 12(4):1203-15. PubMed ID: 25775257
[TBL] [Abstract][Full Text] [Related]
25. Preparation and characterization of spray-dried co-amorphous drug-amino acid salts.
Jensen KT; Blaabjerg LI; Lenz E; Bohr A; Grohganz H; Kleinebudde P; Rades T; Löbmann K
J Pharm Pharmacol; 2016 May; 68(5):615-24. PubMed ID: 26245703
[TBL] [Abstract][Full Text] [Related]
26. Improving the de-agglomeration and dissolution of a poorly water soluble drug by decreasing the agglomerate strength of the cohesive powder.
Allahham A; Stewart PJ; Das SC
Int J Pharm; 2013 Nov; 457(1):101-9. PubMed ID: 24080334
[TBL] [Abstract][Full Text] [Related]
27. Solubility and dissolution performances of spray-dried solid dispersion of Efavirenz in Soluplus.
Lavra ZM; Pereira de Santana D; Ré MI
Drug Dev Ind Pharm; 2017 Jan; 43(1):42-54. PubMed ID: 27349377
[TBL] [Abstract][Full Text] [Related]
28. Influence of the preparation method on the physicochemical properties of indomethacin and methyl-β-cyclodextrin complexes.
Rudrangi SR; Bhomia R; Trivedi V; Vine GJ; Mitchell JC; Alexander BD; Wicks SR
Int J Pharm; 2015 Feb; 479(2):381-90. PubMed ID: 25579867
[TBL] [Abstract][Full Text] [Related]
29. Thermoanalytical and Fourier transform infrared spectral curve-fitting techniques used to investigate the amorphous indomethacin formation and its physical stability in Indomethacin-Soluplus® solid dispersions.
Lin SY; Lin HL; Chi YT; Huang YT; Kao CY; Hsieh WH
Int J Pharm; 2015 Dec; 496(2):457-65. PubMed ID: 26481469
[TBL] [Abstract][Full Text] [Related]
30. Dissolution mechanism of poorly water-soluble drug from extended release solid dispersion system with ethylcellulose and hydroxypropylmethylcellulose.
Ohara T; Kitamura S; Kitagawa T; Terada K
Int J Pharm; 2005 Sep; 302(1-2):95-102. PubMed ID: 16102924
[TBL] [Abstract][Full Text] [Related]
31. Characterization of the molecular distribution of drugs in glassy solid dispersions at the nano-meter scale, using differential scanning calorimetry and gravimetric water vapour sorption techniques.
van Drooge DJ; Hinrichs WL; Visser MR; Frijlink HW
Int J Pharm; 2006 Mar; 310(1-2):220-9. PubMed ID: 16427226
[TBL] [Abstract][Full Text] [Related]
32. Using Flory-Huggins phase diagrams as a pre-formulation tool for the production of amorphous solid dispersions: a comparison between hot-melt extrusion and spray drying.
Tian Y; Caron V; Jones DS; Healy AM; Andrews GP
J Pharm Pharmacol; 2014 Feb; 66(2):256-74. PubMed ID: 24192445
[TBL] [Abstract][Full Text] [Related]
33. A comparative study of the effect of spray drying and hot-melt extrusion on the properties of amorphous solid dispersions containing felodipine.
Mahmah O; Tabbakh R; Kelly A; Paradkar A
J Pharm Pharmacol; 2014 Feb; 66(2):275-84. PubMed ID: 24433426
[TBL] [Abstract][Full Text] [Related]
34. Comparing various techniques to produce micro/nanoparticles for enhancing the dissolution of celecoxib containing PVP.
Homayouni A; Sadeghi F; Varshosaz J; Garekani HA; Nokhodchi A
Eur J Pharm Biopharm; 2014 Sep; 88(1):261-74. PubMed ID: 24952357
[TBL] [Abstract][Full Text] [Related]
35. The formation and physical stability of two-phase solid dispersion systems of indomethacin in supercooled molten mixtures with different matrix formers.
Semjonov K; Kogermann K; Laidmäe I; Antikainen O; Strachan CJ; Ehlers H; Yliruusi J; Heinämäki J
Eur J Pharm Sci; 2017 Jan; 97():237-246. PubMed ID: 27890595
[TBL] [Abstract][Full Text] [Related]
36. Preparation and Characterization of Solid Dispersions of Artemether by Freeze-Dried Method.
Ansari MT; Hussain A; Nadeem S; Majeed H; Saeed-Ul-Hassan S; Tariq I; Mahmood Q; Khan AK; Murtaza G
Biomed Res Int; 2015; 2015():109563. PubMed ID: 26097842
[TBL] [Abstract][Full Text] [Related]
37. In situ preparation of water-soluble ginsenoside Rh2-entrapped bovine serum albumin nanoparticles: in vitro cytocompatibility studies.
Singh P; Kim YJ; Singh H; Ahn S; Castro-Aceituno V; Yang DC
Int J Nanomedicine; 2017; 12():4073-4084. PubMed ID: 28603419
[TBL] [Abstract][Full Text] [Related]
38. Drug-carrier binding and enzymatic carrier digestion in amorphous solid dispersions containing proteins as carrier.
Pas T; Bergonzi A; Lescrinier E; Vergauwen B; Van den Mooter G
Int J Pharm; 2019 May; 563():358-372. PubMed ID: 30935916
[TBL] [Abstract][Full Text] [Related]
39. Fabrication and evaluation of pH-modulated solid dispersion for telmisartan by spray-drying technique.
Marasini N; Tran TH; Poudel BK; Cho HJ; Choi YK; Chi SC; Choi HG; Yong CS; Kim JO
Int J Pharm; 2013 Jan; 441(1-2):424-32. PubMed ID: 23174408
[TBL] [Abstract][Full Text] [Related]
40. Improved dissolution behavior of lipophilic drugs by solid dispersions: the production process as starting point for formulation considerations.
Srinarong P; de Waard H; Frijlink HW; Hinrichs WL
Expert Opin Drug Deliv; 2011 Sep; 8(9):1121-40. PubMed ID: 21722000
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
